Singh, RX, PLLC v. Selective Insurance Company of South Carolina

CourtDistrict Court, E.D. Michigan
DecidedJuly 10, 2024
Docket2:22-cv-12732
StatusUnknown

This text of Singh, RX, PLLC v. Selective Insurance Company of South Carolina (Singh, RX, PLLC v. Selective Insurance Company of South Carolina) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Singh, RX, PLLC v. Selective Insurance Company of South Carolina, (E.D. Mich. 2024).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

SINGH RX, PLLC D/B/A SRX SPECIALTY CARE PHARMACY, A MICHIGAN PROFESSIONAL LIMITED LIABILITY COMPANY, AND AMAN DEEP SINGH, AN INDIVIDUAL,

Plaintiffs,

v.

SELECTIVE INSURANCE COMPANY OF SOUTH CAROLINA, Case No. 22-cv-12732 A NEW JERSEY PROPERTY AND CASUALTY INSURANCE COMPANY, U.S. DISTRICT COURT JUDGE AMERICAN CASUALTY GERSHWIN A. DRAIN COMPANY OF READING, PENNSYLVANIA, A PENNSYLVANIA PROPERTY AND CASUALTY INSURANCE COMPANY, JANSSEN SCIENCES IRELAND UNLMITED COMPANY, AN INTERESTED PARTY, JANSSEN PRODUCTS, LP, AN INTERESTED PARTY, AND JOHNSON & JOHNSON, AN INTERESTED PARTY.,

Defendants. ______________ / OPINION AND ORDER: (1) DENYING PLAINTIFFS’ MOTION FOR JUDGMENT ON THE PLEADINGS, OR ALTERNATIVELY, FOR SUMMARY JUDGMENT AGAINST DEFENDANT SELECTIVE [ECF No. 57]; (2) GRANTING SELECTIVE’S MOTION FOR SUMMARY JUDGMENT [ECF No. 60]; (3) DENYING PLAINTIFFS’ MOTION FOR JUDGMENT ON THE PLEADINGS, OR ALTERNATIVELY, FOR SUMMARY JUDGMENT AGAISNT DEFENDANT AMERICAN CASUALTY [ECF No. 61]; AND (4) GRANTING DEFENDANT AMERICAN CASUALTY’S MOTION FOR SUMMARY JUDGMENT [ECF No. 58; AND (5) CANCELLING BENCH TRIAL AND MOOTING SELECTIVE’S MOTION TO ADJOURN TRIAL [ECF No. 75].

I. Introduction This is an insurance coverage dispute. Plaintiffs Singh RX, PLLC d/b/a SRX Specialty Care Pharmacy (“SRX”) and Aman Deep Singh (“Singh”) (collectively “Plaintiffs”) filed a Complaint for Breach of Contract and Declaratory Relief (the “Complaint”).1 See ECF No. 1. The Complaint names two Defendants: Selective Insurance Company of South Carolina, a New Jersey property and casualty insurance company (“Selective”), and American Casualty Company of Reading Pennsylvania, a property and casualty insurance company (“American Casualty”) (collectively “Defendants”). The dispute arises out of Plaintiffs’ demand that Defendants defend and indemnify them in an underlying lawsuit brought in the United States District Court for the Eastern District of New York by Janssen

1 The Court has diversity jurisdiction under 28 U.S.C. § 1332(a)(1) and (3). Sciences Ireland Unlimited Company, Janssen Products, LP, and Johnson & Johnson (the “Janssen Lawsuit”), discussed in greater detail infra.

Now before the Court are several motions. First, Plaintiffs filed a Motion for Judgment on the Pleadings or Alternatively Summary Judgment Against Defendant Selective Insurance Company of South Carolina on January 15, 2024. See ECF No.

57. Selective responded on February 13, 2024, and Plaintiffs replied on March 5, 2024. See ECF Nos. 65 and 72. Second, Defendant American Casualty filed a Motion for Summary Judgment on January 16, 2024. See ECF No. 58. Plaintiffs responded on February

13, 2024, and American Casualty Company replied on March 5, 2024. See ECF Nos. 68 and 70. Third, Selective filed a Motion for Summary Judgment on January 16, 2024.

See ECF No. 60. Plaintiffs responded on February 13, 2024, and Selective replied on March 5, 2024. See ECF Nos. 67 and 69. Lastly, Plaintiffs filed a Motion for Judgment on the Pleadings or Alternatively Summary Judgment Against American Casualty on January 16,

2024. See ECF No. 61. American Casualty responded on February 13, 2024, and Plaintiffs replied on March 5, 2024. See ECF Nos. 66 and 71. The Court held oral argument on June 25, 2024. For the reasons set forth

below: 1) ECF No. 57: Plaintiffs’ Motion for Judgment on the Pleadings or Alternatively Summary Judgment Against Defendant Selective Insurance Company of South Carolina is DENIED;

2) ECF No. 60: Selective’s Motion for Summary Judgment is GRANTED;

3) ECF No. 61: Plaintiffs’ Motion for Judgment on the Pleadings or Alternatively Summary Judgment Against American Casualty is DENIED;

4) ECF No. 58: Defendant American Casualty’s Motion for Summary Judgment is GRANTED.

5) ECF No. 75: Selective’s motion to adjourn trial is MOOT and the bench trial scheduled for July 15, 2024, is cancelled.

II. Factual Background

SRX is a pharmacy that operates in Royal Oak, Michigan. Singh is a pharmacist and the principal of SRX. The subject matter of this dispute pertains to two separate insurance policies issued by Selective and American Casualty. Selective issued a Businessowners and Commercial Umbrella Policy to SRX for a period beginning on October 19, 2021, and ending October 19, 2022 (the “Business Owners Policy” and the “Commercial Umbrella Policy”). See ECF No. 18-1. American Casualty issued a Professional Liability Policy to SRX with an effective period of March 26, 2021 to March 26, 2022. See ECF No. 1-3, PageID.247. In June 2021, Janssen, a pharmaceutical company, allegedly notified SRX that a prescription for “Symutza,” an antiviral medication used to treat HIV type 1, was filled from SRX. Though the bottle had “Symutza” on the label, it contained Prezcobix, a different prescription medicine used to treat HIV type 1.2 ECF No. 60-

2, PageID.1909. Symutza is a Janssen product. Singh allegedly discussed the issue with “Harris,” a drug representative for a wholesaler (Safe Chain) from whom Plaintiffs had purchased pharmaceuticals, but SRX allegedly failed to stop

purchasing from Safe Chain. Id. at PageID.1913-1917. From July 2021 through July 2022, six letters addressed to Singh RX were sent by counsel for Janssen, inter alia, advising Plaintiffs of issues concerning the purchase and disbursement of counterfeit HIV medications. They also requested

that Plaintiffs quarantine specified medication and comply with subpoenas related to two separate legal matters. See ECF Nos. 60-2, PageID.1920-30; ECF Nos. 60- 5, 60-7, 60-8, 60-9, and 60-10. However, Singh testified that he did not recall

receiving the letters. See ECF No. 60-2, PageID.1921. The Janssen Lawsuit was filed on April 7, 2022, in the United States District Court for the Eastern District of New York by Johnson & Johnson and two subsidiaries: Janssen Sciences Ireland Unlimited Company and Janssen Products,

LP (the “Janssen plaintiffs”). The complaint was amended on December 20, 2022.

2 According to Janssen’s complaint, “SYMTUZA® is a complete, single-tablet, once-a-day medication that contains an entire HIV combination therapy regimen in a single pill.” ECF No. 1-4, PageID.325. By contrast, “PREZCOBIX® is not a complete HIV regimen” and must be used with “at least one other antiretroviral medication.” Id. Janssen alleges that the product and supply chain pedigree were counterfeit. Id., at PageID.329. It alleged that “SRX bought hundreds of counterfeit bottles from Safe Chain and Brooklyn-based Scripts long after a counterfeit,” purchased by SRX from Safe

Chain and dispensed to a customer, “was detected and brought to SRX’s attention.” ECF No. 17-3, PageID.1149. The complaint also alleged that “[s]ince the Wholesaler Defendants stopped selling HIV medication, SRX has been

obtaining Janssen-branded HIV medication of unknown origin from unidentified unauthorized distributors.” Id. The Janssen plaintiffs asserted the following claims against SRX and Singh: (1) Count I, federal trademark infringement in violation of 15 U.S.C. § 1114(1)(a)

(use of trademarks without consent in the sale of “counterfeit” products (ECF No. 1-5, PageID.475); (2) Count II, federal trademark infringement in violation of 15 U.S.C. § 1114(1)(b) (use of trademarked labels on counterfeit bottles) (ECF No. 1-

5, PageID.476); (3) Count III, “false description and designation of origin in commerce” in violation of 15 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Reid v. Oklahoma Pardon & Parole Board
67 F. App'x 515 (Tenth Circuit, 2003)
DeFRAIN v. STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY
817 N.W.2d 504 (Michigan Supreme Court, 2012)
Kuznar v. Raksha Corp.
750 N.W.2d 121 (Michigan Supreme Court, 2008)
City of Warren v. International Insurance Company
524 F. App'x 254 (Sixth Circuit, 2013)
Hirst v. St. Paul Fire & Marine Insurance
683 P.2d 440 (Idaho Court of Appeals, 1984)
Auto-Owners Insurance v. Churchman
489 N.W.2d 431 (Michigan Supreme Court, 1992)
Bianchi v. AUTO CLUB OF MICH.
467 N.W.2d 17 (Michigan Supreme Court, 1991)
Citizens Insurance v. Secura Insurance
755 N.W.2d 563 (Michigan Court of Appeals, 2008)
Heniser v. Frankenmuth Mutual Insurance
534 N.W.2d 502 (Michigan Supreme Court, 1995)
American Bumper and Manufacturing Co. v. Hartford Fire Ins. Co.
550 N.W.2d 475 (Michigan Supreme Court, 1996)
Marx v. Hartford Accident and Indemnity Company
157 N.W.2d 870 (Nebraska Supreme Court, 1968)
American Fellowship Mutual Insurance v. Insurance Co. of North America
282 N.W.2d 425 (Michigan Court of Appeals, 1979)
Century Surety Co. v. Charron
583 N.W.2d 486 (Michigan Court of Appeals, 1998)
Auto-Owners Insurance v. City of Clare
521 N.W.2d 480 (Michigan Supreme Court, 1994)
St Paul Fire & Marine Insurance v. Quintana
419 N.W.2d 60 (Michigan Court of Appeals, 1988)
Royce v. Citizens Insurance
557 N.W.2d 144 (Michigan Court of Appeals, 1997)
Michigan Educational Employees Mutual Insurance v. Turow
617 N.W.2d 725 (Michigan Court of Appeals, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Singh, RX, PLLC v. Selective Insurance Company of South Carolina, Counsel Stack Legal Research, https://law.counselstack.com/opinion/singh-rx-pllc-v-selective-insurance-company-of-south-carolina-mied-2024.